Dr. Anil K. Patri

National Cancer Institute at Frederick
Frederick, Maryland

Dr. Anil K. Patri is a Senior Scientist in the Nanotechnology Characterization Laboratory (NCL) at the National Cancer Institute at Frederick. His expertise is in the interface of chemistry and biology pertaining to nanomaterial. Dr. Patri directs a chemistry lab at NCL and collaborates with scientists from the National Institute of Standards and Technology (NIST) and Food and Drug Administration (FDA) for the physico-chemical characterization and assessment of nanomaterial intended for cancer therapeutic and diagnostic applications.

Prior to joining NCL, Dr. Patri served as a staff scientist at the Center for Biologic Nanotechnology (now MNIMBS) at the University of Michigan and developed nanomaterial for targeting, imaging, and drug delivery application to cancer. His graduate and post-doctoral training were on the synthesis, modification, and application of dendrimers to material and biomedical applications. He received his Ph.D. in Organic chemistry from the University of South Florida, M.Sc., in Organic Chemistry from Aligarh University, and B.Sc., in Biology and Chemistry from Osmania University, India.